Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Seward Recruits European Sales Manager for Laboratory Sample Preparation Products

Published: Tuesday, May 01, 2012
Last Updated: Tuesday, May 01, 2012
Bookmark and Share
Seward’s European customers and distribution network to benefit from enhanced support.

Seward Ltd, the manufacturer and developer of the patented Stomacher® Paddle Blender range, has recruited Gary Ross as European Sales Manager to its growing team. Drawing on years of experience, Gary will enhance support and information flow on Seward’s broad range of sample preparation products to its distribution network, covering its large and expanding European customer base.

Fluent in Spanish and English and with practical knowledge of the food and beverage industry, Gary Ross has spent many years working with distributors, giving him an excellent understanding of their commercial needs. He is also ideally placed to offer sales support, training and access to technical assistance where required. A better informed distributor network will ultimately ensure that end users of Seward Stomacher products can more readily secure any assistance that they may require.

“We are very pleased to welcome Gary to the Seward team,” said Howard Matthews, Director of Sales and Marketing, Seward Ltd., “By providing more regular direct contact with our European customers, we aim to ensure that they are better supported and able to secure in person answers to questions and receive assistance with all their sample preparation needs in a number of industry sectors, including food, environmental and life science.”

The Stomacher® paddle blender range has been proven in laboratories around the world to be a valuable tool in industry, research, education and healthcare. In scientific procedures the quality of the sample and its preparation are critical to accurate results, Stomacher has been and continues to be developed to achieve this.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,200+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Editing Gene Mutations in Anemia
Researchers successfully use a new gene editing strategy to correct mutations that cause a form of anemia.
Nanomedicine Aims to Improve HIV Drug Therapies
New research aims to improve the administration and availability of drug therapies to HIV patients using nanotechnology.
Observing Direct Inheritance of Gene-Silencing RNA
Research has allowed for the observation of double-stranded RNA molecule being passed from parent to offspring in roundworms.
Fighting Cancer with Immune Response
New treatment elicits two-pronged immune response that destroys tumors in mice.
First Entirely 3D-printed Organ-on-a-Chip with Integrated Sensors
New approach to manufacturing may allow researchers to rapidly design organs-on-chips that match the properties of a specific disease or individual patient's cells.
Nanoparticles Offer Promising Platform for Flavivirus Treatment
New nanoparticle effectively vaccinated mice against one dengue strain and could be created to target all four.
Study Finds Key Regulator in Pulmonary Fibrosis
Researchers identify an enzyme that could open the way to therpies for chronic fatal lung disease.
Signaling Pathway Could Be Key to Improved Osteoporosis Treatment
Inhibition of SIK2 enzyme both stimulates bone formation and reduces bone breakdown in animal model.
Ovarian Cancer Insight
Study showed tumours release cytokines to attract macrophages, which secrete growth factors that in turn promote tumour growth.

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos